Philips recently introduced a second-generation innovative wearable medical device that uses UV-resistant blue LED illuminators to help patients with mild or moderate plaque psoriasis (also known as psoriasis) control their condition.
Following the successful launch of the wearable medical device in the Netherlands, Germany and the UK in late 2014 and in France in early 2015, a new generation of clinical test medical devices was developed based on user insights and feedback. Philips BlueControl 2.0 has been launched in Denmark, Sweden and Finland and will be introduced in Poland, Belgium, Austria, Switzerland and Hong Kong in the coming months. Markets such as Israel and Italy are not expected to use the device until 2016.
It is reported that there are 125 million psoriasis patients worldwide, 80% of which are affected by the most common psoriasis vulgaris.
Blue LEDs primarily treat plaque symptoms by inducing natural changes in the skin. Blue light can help skin renewal by inhibiting accelerated division of plaque psoriasis cells. In addition, it can effectively control skin inflammation. Philips BlueControl is a mild UV-resistant phototherapy device that uses visible light to induce a natural reduction in skin redness, spread and thickness. The UV-resistant blue LED phototherapy device is tailored to the light of 40 high-intensity blue LEDs. Philips has designed a low-key bundle of components for BlueControl that provides energy for the battery, and patients can fix it in various parts of the body to relieve the disease.
Full/Half Height Turnstile ,Half Height Turnstile ,Full Height Turnstile ,Access Control Turnstile
Shenzhen Unisec Technology Co.,ltd , https://www.uniqscansecurity.com